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bypassing the striatal afferent and efferent fibers (Nambu et al., 2000) and excite the output 117 nuclei. Dopaminergic projections modulate the CBG pathways by activating the D1 and D2 118 receptors in the striatum. Dopamine (DA) has opposing effects on these pathways by facilitating 119 the "direct pathway" through the D1 receptors and inhibiting the "indirect pathway" through the 120 D2 receptors expressed in neurons belonging to these pathways (Gerfen et al., 1990 ). Hence, 121 higher levels of DA in the striatum increases cortical activation, whereas decreased DA levels 122 suppress cortical activation (Albin et al., 1989; DeLong, 1990) .
123
Striatal neurons can be divided into two populations: projection neurons and interneurons. This is beneficial as the direct study of such disorders typically presents a large challenge in the 192 quantification of behavior.
193
The dopaminergic models use systemic or focal administration of DA agonists such as 
Physiology of Tourette syndrome
228
The behavioral expression of TS symptoms has been studied for over a century; however, the 229 underlying neuronal abnormalities have only been studied extensively in the last two decades.
230
Physiological data which historically have been limited to non-invasive methods is currently 231 being augmented by invasive electrophysiological recordings in human patients undergoing 232 neurosurgery, and novel experimental animal models. Research using animal models of TS focused historically on behavioral properties and the effects 
309
Unlike most current models, the striatal disinhibition animal model of TS enables the study of 
336
Complex response patterns were also found in the output nuclei of the BG; i.e., the GPi and the 
388
Indirect support for the action selection model and its malfunction in TS is provided by 389 recordings in human TS patients undergoing surgery (Table 1B) . These patients were seen to 
Deep brain stimulation
407
A novel approach to treating severe cases of TS which are non-responsive to behavioral and 408 pharmacological treatments is a neurosurgical approach termed deep brain stimulation (DBS).
409
This treatment, which has been previously applied successfully to multiple movement and 410 psychiatric disorders, is used in an exploratory manner in TS. 
Deep brain stimulation in movement disorders
412
The development of stereotaxic surgery enabled accurate access to deep brain structures for 413 patients suffering from different disorders (Spiegel et al., 1947 
Deep brain stimulation in obsessive-compulsive disorder
Deep brain stimulation in Tourette syndrome
467
The dramatic therapeutic benefits of DBS in movement disorder and early successes in proposed, primarily within the CBG loop ( Fig. 1; Table 2 ), in an attempt to select appropriate targets for the alleviation of both tics and comorbid symptoms. Regions of the medial thalamus 474 are the most commonly used targets due to their involvement in both motor and limbic pathways.
475
Preliminary studies of thalamic DBS were performed under the assumption that bilateral 
Physiological effects of DBS
528
DBS surgery for different neurological disorders is a success story. However, despite its growing 529 popularity, its underlying mechanism in general and its specific neurophysiological effects on 530 each of the disorders remains obscure. A multitude of studies in human patients undergoing 531 surgery and in animal models have greatly improved our understanding of the mechanism over 532 the last decade. Only a very small fraction of these studies has been performed for TS; however, the larger body of evidence from other CBG related disorders (such as PD) provides valuable 534 information, and hints at its potential mechanism in TS. 
Neurophysiological effect of DBS in PD
536
The mechanism of action of DBS has been studied most extensively in PD. This is a result of 
Neurophysiological effect of DBS in TS
573
The vast majority of the 100+ reported cases of TS DBS has focused on the clinical outcomes 
Summary and conclusions
631
The growing popularity of DBS treatment as a therapeutic option for controlling the symptoms 
